Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Öz

Background and objective: Endovascular treatment for bleeding control in the hemoptysis
was first performed and described in 1970’s. In the present day, bronchial
artery embolization is performed for all degrees of hemoptysis in benign and
malign pathologies. Case series to evaluate patients’ demographics, angiographic
findings, technical success of treatment, and early clinical success were
presented.Material-Methods: Between 2007-2018, the patients with hemoptysis
undergoing angiographic evaluation were included the study in Interventional
Radiology Unite. Patients’ demographics, angiographic findings, technical
success of treatment, and early clinical success were evaluated.Results: Thirty-seven patients who had angiographic pathologic
signs from 47 patients with hemoptysis were treated 91.8 % technical success
(n=34). Early stage clinical success, during the length of hospital stay or the
first month period, was achieved in 31 (91%) patients. The main angiographic
abnormality was parenchymal staining and the first choice agents were polyvinyl
alcohol (PVA) for embolization. There were no complications related to the
procedure. Conclusions: Results suggest that endovascular treatment in
patients with hemoptysis is a safe and an effective approach that supports
current literature.